In a new job - April 24, 2017
New CEO of Modus Therapeutics
Modus Therapeutics announces the appointment of Ellen K. Donnelly, Ph.D as Chief Executive Officer. Dr. Donnelly joins Modus Therapeutics from Pfizer, Inc., where she has held numerous leadership positions in Clinical Operations; Project and Portfolio Management; and Research. Most recently she was responsible for Clinical Operations for Pfizer’s Neuroscience and Pain therapeutic area. Dr. Donnelly […]
In a new job - April 24, 2017
Tobias Bäckström new Medical Director at GSK
Tobias Bäckström, GSK’s new Medical Director, will be reporting to both Ebbe Englev, Cluster Medical Director and Niclas Källbom Karlsson, CEO of GSK Sweden, and he will be a part of the Swedish board of directors. “I look very much forward to working at GSK. GSK has exciting research and many novel interesting pharmaceuticals underway,” […]
In a new job - April 22, 2017
Henrik Stenqvist is Recipharm’s new CFO
Recipharm announces the appointment of Henrik Stenqvist as its new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. Henrik Stenqvist will be based at the company’s headquarters in Stockholm and reports to Thomas Eldered, Chief Executive Officer of Recipharm. Stenqvist brings 24 years’ finance and management experience to Recipharm. Prior to […]
In a new job - April 22, 2017
Scandinavian Biopharma recruits new CFO
The Swedish company continues to expand and at the end of February Peter Liss was appointed as Chief Financial Officer (CFO). Peter Liss will be responsible for business development and he has several years of experience as CFO. Most recently he was CEO and CFO at Valneva Sweden and he has also had similar positions […]
In a new job - April 15, 2017
Guido Oelkers appointed President and CEO at Sobi
Swedish Orphan Biovitrum announces that Guido Oelkers has been appointed President and Chief Executive Officer effective as of 22 May 2017, succeeding Geoffrey McDonough. Guido Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH. He has extensive experience from pharmaceutical and health care companies including a role as President and CEO […]
In a new job - April 15, 2017
Elekta appoints new Chief Financial Officer
Gustaf Salford has been appointed Executive Vice President and Chief Financial Officer at Elekta, effective July 1, 2017. Salford will be succeeding Håkan Bergström, who will retire per the same date. Salford joined Elekta in 2009 and has worked in several financial leadership roles within the company, most recently as Head of Group Business Control. […]
